Plasma exchange: Why we do what we do

Journal of Clinical Apheresis

Volumn 17, Issue 4, 2002, Pages 207-211

  Brecher, Mark E ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; IMMUNOGLOBULIN G;

BLOOD CLOTTING; BLOOD VOLUME; CELL SEPARATION; CLINICAL PRACTICE; CONFERENCE PAPER; PLASMAPHERESIS; TIME; TREATMENT PLANNING;

BLOOD COAGULATION; HUMANS; IMMUNOGLOBULINS; KINETICS; PLASMA EXCHANGE; SOLUTIONS;

EID: 0036912653     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/jca.10041     Document Type: Conference Paper

References (24)

1. McLeod BC, Sniecinski I, Ciavarella D, Owen H, Price TH, Randels MJ, Smith JW. Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion 1999;39:282-288.
2. McCullough J, Chopek M. Therapeutic plasma exchange. Lab Med 1981;12:745-753.
3. Bourke DL, Smith TC. Estimating allowable hemodilution. Anesthesiology 1974;41:609-612.
4. Brecher ME, editor. AABB Technical Manual. Bethesda, MD: American Association of Blood Banks, 14th edition, 2002.
5. Dau PC. Plasmapheresis therapy in myasthenia gravis. Muscle Nerve 1980;3:468-482.
6. Chirnside A, Uraniak SJ, Powse CV, Keller AJ. Coagulation abnormalties following intensive plasma exchangeon the cell separator, II: Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III. Br J Haematol 1981;48:627-634.
7. Sultan Y, Bussel A, Maisonneuve P, et al. Potential danger of thrombosis after plasma exchange in the treatment of patients with immune disease. Transfusion 1979;19:588-93
8. Flaum MA, Cuneo RA, Appelbaum FR, Deisseroth AB, Engel WK, Gralnik HR. The hemostatic imbalance of plasmaexchange transfusion. Blood 1979;54:694-702.
9. Wood L, Jacobs P. The effect of therapeutic plasmapheresis on platelet count, coagulation factors, plasmaimmunoglobulin, and complement levels. J Clin Apheresis 1986;3;124-128.
10. Keller AJ, Chirnside A, Urbaniak SJ. Coagulation abnormalities produced by plasma exchange on the cell separator with special reference to fibrinogen and platelet levels. Br J Haematol 1979;42:593-603.
11. Domen E, Kennedy MS, Jones LL, Senhauser DA. Hemostatic imbalances produced by plasma exchanges. Transfusion 1984;24:336-339.
12. Owen HG, Koo A, McAteer M, Brecher ME. Evaluation of platelet loss during TPE on the COBE SPECTRA. J Clin Apheresis 1997;12:28.
13. Lasky LC, Finnerty EP, Glenis L, Polesky HF. Protein and colloid osmotic pressure changes with albumin and/or saline replacement during plasma exchange. Transfusion 1984;24: 256-259.
14. McLeod BC, Sassetti RJ, Stefoski D, Davis FA. Partial plasma protein replacement in therapeutic plasma exchange. J Clin Apheresis 1983;1:115-118.
15. Owen, HG, Brecher ME. Atypical reactions associated with ACE inhibitors and apheresis. Transfusion. 1994;34:891-894.
16. Brecher ME, Owen HG. Washout kinetics of colloidal starch as a partial or full replacement for plasma exchange. J Clin Apheresis 1996;11:123-126.
17. Owen HG, Brecher ME. Partial colloid replacement for therapeutic plasma exchange. J Clin Apheresis 1997;12:87-92.
18. Brecher ME, Owen HG, Bandarenko N. Alternatives to albumin: Starch replacement for plasma exchange. J Clin Apheresis 1997;12:146-153.
19. Owen HG, Brecher ME, Howard JF, Bandarenko N. Minimizing hypovolemic reactions with 3% hetastarch replacement during therapeutic plasma exchange. J Clin Apheresis 14:91 (abstr).
20. Gross AG, Weinstein R. Pentastarch as partial replacement fluid for therapeutic plasma exchange: Effect on plasma proteins, adverse events during treatment, and serum ionized calcium. J Clin Apheresis 1999;14:114-121
21. Steinmuller DR. A dangerous error in the dilution of 25 percent albumin. N Engl J Med 1998;338:1226-1227 (letter).
22. Pierce LR, Gaines A, Varricchio F, Epstein J. Hemolysis and renal failure associated with the inappropriate use of sterile water to dilute human albumin 25%. N Engl J Med 1998; 338:1226-1227
23. Pierce LR, Gaines A, Finlayson JS, Varricchio F, Epstein JS. Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water [letter]. Transfusion. 1999; 39:110-111.
24. Bandarenko N, Brecher ME. United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apheresis 1998;13:133-141.